Pharmacoeconomic Evaluation For Most Common Life Style Diseases & Their Compelling Indications Of Patients Admitted In A Tertiary Care Hospital

Abstract

Lifestyle diseases share risk factors similar to prolonged exposure to three modifiable lifestyle behaviours smoking, unhealthy diet, and physical inactivity -- and result in the development of chronic diseases, specifically heart disease, stroke, diabetes, obesity, metabolic syndrome, chronic obstructive pulmonary disease, and some types of cancer. These illnesses used to be considered the diseases of industrialized countries, so-called "Western diseases" or "diseases of affluence"; however, internationally they are known as non-communicable and chronic diseases, part of the degenerative diseases group. Chronic disease can result in loss of independence, years of disability, or death, and impose a considerable economic burden on health services. Pharmacoeconomics is a scientific discipline that compares the costs and consequences of drug therapies and medical interventions. The main objective of this study is to assess the various Anti-hypertensive drugs and oral hypoglycemic receiving by the patients at a tertiary care hospital for hypertension and diabetes and to evaluate the expenses involved in different treatments, also evaluate the cost effectiveness analysis and determine which of the treatments for hypertension and diabetes is most cost effective. This study also discussed about assess the rational use of Anti-hypertensive drugs and oral hypoglycemics.